TY - JOUR
T1 - Erratum
T2 - Editor's note: Inhibition of platelet-derived growth factor–mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571 (Clin Cancer Res (2019) 8:3584–91))
AU - McGary, Eric C.
AU - Weber, Kristy
AU - Mills, Lisa
AU - Doucet, Michelle
AU - Lewis, Valerie
AU - Lev, Dina Chelouche
AU - Fidler, Isaiah J.
AU - Bar-Eli, Menashe
N1 - Publisher Copyright:
© 2019 American Association for Cancer Research.
PY - 2019
Y1 - 2019
N2 - The editors are publishing this note to alert readers to a concern about this article (1): Figure 2 is missing a splice line in the lanes between PDGF-BB 50 and 10, and the original data are not available for review. Reference 1. McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, et al. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 2002;8:3584–91.
AB - The editors are publishing this note to alert readers to a concern about this article (1): Figure 2 is missing a splice line in the lanes between PDGF-BB 50 and 10, and the original data are not available for review. Reference 1. McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, et al. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 2002;8:3584–91.
UR - http://www.scopus.com/inward/record.url?scp=85065768195&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-19-1101
DO - 10.1158/1078-0432.CCR-19-1101
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
C2 - 31092620
AN - SCOPUS:85065768195
SN - 1078-0432
VL - 25
SP - 3196
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 10
ER -
